EPS (Diluted) for STERIS (STE)
According to STERIS's latest reported financial statements, the company's current diluted EPS (TTM) is $7.17. Diluted earnings per share (EPS) is net income divided by the diluted weighted-average shares outstanding over the period. It expresses profit on a per-share basis — the figure investors use to value an individual share — and accounts for potential dilution from options, RSUs, and convertible securities.
Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .
STE
Currently viewingEPS (Diluted)Switch metric
TTM (last 4 quarters)
$7.17
YoY change
+62.7%
5Y CAGR
+5.4%
Peak year (2025)
$6.20
Latest annual
$6.20
EPS (Diluted) history chart for STERIS (STE) from 1991 to 2025
EPS (Diluted) history table for STERIS (STE) from 1991 to 2025
| Fiscal year | Period ended | Reported | EPS (Diluted) | YoY |
|---|---|---|---|---|
| 2025 | $6.20 | +62.7% | ||
| 2024 | $3.81 | +256.1% | ||
| 2023 | $1.07 | -56.9% | ||
| 2022 | $2.48 | -46.4% | ||
| 2021 | $4.63 | -2.7% | ||
| 2020 | $4.76 | +33.7% | ||
| 2019 | $3.56 | +5.0% | ||
| 2018 | $3.39 | +164.8% | ||
| 2017 | $1.28 | -17.9% | ||
| 2016 | $1.56 | -30.7% | ||
| 2015 | $2.25 | +3.7% | ||
| 2014 | $2.17 | -20.2% | ||
| 2013 | $2.72 | +17.7% | ||
| 2012 | $2.31 | +171.8% | ||
| 2011 | $0.85 | -60.6% | ||
| 2010 | $2.16 | +16.1% | ||
| 2009 | $1.86 | +55.0% | ||
| 2008 | $1.20 | -4.0% | ||
| 2007 | $1.25 | +22.5% | ||
| 2006 | $1.02 | -17.1% | ||
| 2005 | $1.23 | -7.5% | ||
| 2004 | $1.33 | +18.7% | ||
| 2003 | $1.12 | +72.3% | ||
| 2002 | $0.65 | +3150.0% | ||
| 2001 | $0.02 | -86.7% | ||
| 2000 | $0.15 | -87.5% | ||
| 1999 | $1.20 | +26.3% | ||
| 1998 | $0.95 | -311.1% | ||
| 1997 | $-0.45 | -250.0% | ||
| 1996 | $0.30 | -314.3% | ||
| 1995 | $-0.14 | -286.7% | ||
| 1994 | $0.07 | +275.0% | ||
| 1993 | $0.02 | -260.0% | ||
| 1992 | $-0.01 | -16.7% | ||
| 1991 | $-0.01 | — |
EPS (Diluted) values are taken from STERIS's reported income statements (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
Analysis
The 2025 reading of STERIS (STE) diluted EPS is $6.20 – surged 62.7% year-over-year.
Looking at the 2020–2025 (5 years) stretch, STERIS diluted EPS compounded at +5.4% per year, sustaining 2 straight years of year-over-year growth.
The dataset's maximum diluted EPS sits at $6.20 (2025); the minimum reading of $-0.45 dates to 1997.
STERIS (STE) sits 8th of 8 Healthcare peers we track on this metric, against a peer median of $13.16.
STERIS EPS (Diluted) by Year
STERIS EPS (Diluted) 2025: $6.20
STERIS diluted EPS in 2025 was $6.20, surged 62.7% from 2024. This figure represents the highest annual value in the available history.
STERIS EPS (Diluted) 2024: $3.81
STERIS diluted EPS in 2024 was $3.81, surged 256.1% from 2023.
STERIS EPS (Diluted) 2023: $1.07
STERIS diluted EPS in 2023 was $1.07, plunged 56.9% below 2022.
STERIS EPS (Diluted) 2022: $2.48
STERIS diluted EPS in 2022 was $2.48, plunged 46.4% below 2021.
STERIS EPS (Diluted) 2021: $4.63
STERIS diluted EPS in 2021 was $4.63.
See more financial history for STERIS (STE).
Sector peers — EPS (Diluted)
Companies in the same sector as STERIS, ranked by their latest diluted EPS.
| Company | EPS (Diluted) | Sector |
|---|---|---|
| Novo Nordisk A/S (NVO) | $23.03 | Healthcare |
| Eli Lilly and Company (LLY) | $22.95 | Healthcare |
| Amgen Inc. (AMGN) | $14.23 | Healthcare |
| UnitedHealth Group Incorporated (UNH) | $13.23 | Healthcare |
| AstraZeneca PLC (AZN) | $13.08 | Healthcare |
| Johnson & Johnson (JNJ) | $11.03 | Healthcare |
| Merck & Co., Inc. (MRK) | $7.28 | Healthcare |
| AbbVie Inc. (ABBV) | $2.37 | Healthcare |
Frequently asked questions
What is STERIS's diluted EPS?
- Latest reported diluted EPS for STERIS (STE) is $7.17 (period ending December 31, 2025).
How has STERIS diluted EPS changed year-over-year?
- STERIS (STE) diluted EPS changed +62.7% year-over-year on the latest annual filing.
What is the long-term growth rate of STERIS diluted EPS?
- STERIS (STE) diluted EPS compound annual growth rate is +5.4% over the most recent 5 years available.
When did STERIS diluted EPS hit its highest annual value?
- STERIS diluted EPS reached its highest annual value of $6.20 in 2025.
What was STERIS diluted EPS in 2024?
- STERIS (STE) diluted EPS in 2024 was $3.81.
What was STERIS diluted EPS in 2025?
- STERIS (STE) diluted EPS in 2025 was $6.20.
Metrics overview
Pick a metric for charts, filings, and peers — each row shows the latest TTM or annual value with year-over-year change.
Explore more
STE Overview
Company profile, financial tools, and key metrics
STE Revenue Counter
Earns $184.81 every second. See per minute, hour, and day.
STE Earnings Counter
Earns $22.44 per second net profit. See per minute, hour, and day.
STE Economic Scale
Exceeds Eswatini's GDP. Compare with world economies.
STE What If Invested
What if you had invested $1,000? See historical returns from any date.
STE How It Makes Money
Discover visual breakdown of $5.83B in revenue — where it comes from and where it goes.
STE Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
STE Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
STE Daily Price Character
Balanced · 49.9% historical win rate (green days). Streaks & record days.
STE Buybacks
0.83% TTM buyback yield. Shareholder yield & SBC comparison.
STE Stock Split History
2 splits on record. Dates, ratios, and cumulative multiple.
STE Dividend Profile
Yield: 1.16%. Safety: 7/7. See full history.
STE Dividend Calculator
How much dividend income would $1,000 have earned? Calculate from any date.
STE Dividend Forecast
Project future income with DRIP, growth assumptions, and optional monthly contributions.